Accessibility Menu

Qiagen(FRA) QIA

Market Cap€7.65BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1996)+553%
5 Year-30%
1 Year-12%
1 Month+5%
€37.17
+0.07%
+0.02Today
Qiagen last closing stock price
MetricPriceDate
Last closeEUR 37.472026-09-01
Qiagen stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+2.07%EUR 36.712026-08-25
1 month+4.9%EUR 35.722026-07-31
3 month+20.95%EUR 30.982026-06-03
Year to date-8.36%EUR 40.892025-12-30
1 year-12.31%EUR 42.732025-09-01
3 year-19.19%EUR 46.372023-09-01
5 year-29.78%EUR 53.362021-09-02
Since inception+552.65%EUR 5.691996-09-27

Qiagen Financials at a Glance

Market Cap

€7.65BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€1.80K

Net Income (TTM)

€351.01

EPS (TTM)

€1.69

P/E Ratio

22.00

Dividend

€0.31

Beta (Volatility)

0.05 (Low)

Price

€37.17

Volume

0

Open

€37.17

Previous Close

€37.14

Daily Range

€37.17 - €37.17

52-Week Range

€27.87 - €48.80

Estimated Earnings Date

N/A

QIA News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Qiagen

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.

Industry

Life Sciences Tools and Services

Employees

5,654

CEO

Thierry L. Bernard

QIA Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

11.85%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

4.55%

Dividend Yield

0.82%

Payout Ratio

N/A

Stock Overview

Market Cap

€7.65BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

206.07M

Volume

0

Avg. Volume

1.18K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Qiagen Performance Analysis

Qiagen annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 2,037,650,1757.0%
20232023-12-31EUR 1,817,854,626-10.8%
20242024-12-31EUR 1,828,816,5900.6%
20252025-12-31EUR 1,851,887,1461.3%
Qiagen annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 1.95-6.4%
20232023-12-31EUR 1.53-21.8%
20242024-12-31EUR 0.37-75.6%
20252025-12-31EUR 1.81386.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€460.17

+1.0%

Gross Profit

€290.70

+1.0%

Gross Margin

63.17%

+1.0%

Market Cap

€7.65BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

€1.25

N/A

Employees

5,654

N/A

Net Income

€88.93

+1.0%

EBITDA

€164.58

+1.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€2.11K

+13.7%

Total Debt

€1.44K

+1.2%

Accounts Receivable

€348.42

+1.1%

Inventory

€272.33

+1.1%

Long Term Debt

€1.42K

+1.9%

Short Term Debt

€14.45

+0.0%

Return on Assets

6.94%

+1.0%

Return on Invested Capital

7.39%

+1.0%

Free Cash Flow

€135.97

+1.4%

Operating Cash Flow

€173.14

+1.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
WETOWetour Robotics
$5.48-0.04%
TQQQProShares Trust - ProShares UltraPro Qqq
$71.92+0.00%
IBITiShares Bitcoin Trust
$44.67+0.02%
INTCIntel
$89.51+0.00%

Questions About QIA

What is the current price of Qiagen?

Qiagen is trading at €37.17 per share.

What is the 52-week range for Qiagen?

Over the past 52 weeks, Qiagen has traded between €27.87 and €48.80.

How much debt does Qiagen have?

As of the most recent reporting period, Qiagen reported total debt of €1.44B.

How much cash does Qiagen have on hand?

Qiagen reported €672.18M in cash and cash equivalents in its most recent financial results.

What is Qiagen’s dividend yield?

Qiagen currently has a dividend yield of 0.82%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.